$ARAT
Arax Holdings Corp

2023 Q2 Form 10-Q Financial Statement

#000175392623000809 Filed on June 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $226.9K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $226.9K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $1.208M $13.05K
YoY Change 9159.16% -85.98%
% of Gross Profit 532.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit 0.0%
Operating Expenses $1.208M $13.05K
YoY Change 9159.18% -85.98%
Operating Profit -$981.4K -$13.05K
YoY Change 7422.32%
Interest Expense -$28.89K
YoY Change
% of Operating Profit
Other Income/Expense, Net $713.1K
YoY Change
Pretax Income -$268.3K -$13.05K
YoY Change 1955.95% -85.98%
Income Tax
% Of Pretax Income
Net Earnings -$13.05K -$13.05K
YoY Change -0.02% -85.98%
Net Earnings / Revenue -5.75%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share $0.00 -$1.263K
COMMON SHARES
Basic Shares Outstanding 114.3M shares
Diluted Shares Outstanding 109.5M shares 10.34M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $542.9K
Short-Term Investments
Other Short-Term Assets $542.9K
YoY Change
Inventory
Prepaid Expenses
Receivables $453.8K
Other Receivables $0.00
Total Short-Term Assets $542.9K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $18.55M
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $19.00M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $542.9K
Total Long-Term Assets $19.00M
Total Assets $19.55M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.625K
YoY Change
Accrued Expenses $43.39K $12.50K
YoY Change 247.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $437.5K $62.68K
YoY Change 598.01% 984.43%
LONG-TERM LIABILITIES
Long-Term Debt $518.5K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $518.5K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $437.5K $62.68K
Total Long-Term Liabilities $518.5K $0.00
Total Liabilities $956.0K $62.68K
YoY Change 1425.23% 984.43%
SHAREHOLDERS EQUITY
Retained Earnings -$2.203M
YoY Change
Common Stock $109.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.59M -$62.68K
YoY Change
Total Liabilities & Shareholders Equity $19.55M
YoY Change

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$13.05K -$13.05K
YoY Change -0.02% -85.98%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$1.182M $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$18.55M
YoY Change
Cash From Investing Activities -$18.55M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.28M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.182M 0.000
Cash From Investing Activities -18.55M
Cash From Financing Activities 20.28M 0.000
Net Change In Cash 547.5K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$1.182M $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001566243
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Entity Address State Or Province
EntityAddressStateOrProvince
WY
CY2022Q4 us-gaap Assets Current
AssetsCurrent
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2023Q2 arat Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
usd
CY2022Q2 arat Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
usd
arat Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
usd
arat Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10335924 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10335924 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-185928
dei Entity Registrant Name
EntityRegistrantName
ARAX HOLDINGS CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0376721
dei Entity Address Address Line1
EntityAddressAddressLine1
30 N Gould Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Sheridan
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
82801
dei City Area Code
CityAreaCode
(850)
dei Local Phone Number
LocalPhoneNumber
254-1161
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
114285969 shares
CY2023Q2 us-gaap Assets Current
AssetsCurrent
542921 usd
CY2023Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
453772 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
18550285 usd
CY2023Q2 us-gaap Assets
Assets
19546978 usd
CY2022Q4 us-gaap Assets
Assets
0 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1625 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
43391 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
116869 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
340713 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
57756 usd
CY2023Q2 arat Gain Or Loss
GainOrLoss
-5969 usd
CY2022Q4 arat Gain Or Loss
GainOrLoss
57756 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
437515 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
174625 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
518500 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
518500 usd
CY2023Q2 us-gaap Liabilities
Liabilities
956015 usd
CY2022Q4 us-gaap Liabilities
Liabilities
174625 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109459182 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109459182 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10335924 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10335924 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
109459 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10335 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20674801 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
684046 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2203297 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-879006 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18590963 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-174625 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19546978 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023Q2 us-gaap Revenues
Revenues
226886 usd
us-gaap Revenues
Revenues
453772 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1208323 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13047 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1420663 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36663 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1208323 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
13047 usd
us-gaap Operating Expenses
OperatingExpenses
1420663 usd
us-gaap Operating Expenses
OperatingExpenses
36663 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-981437 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13047 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-966891 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-36663 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
713136 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-335493 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-268301 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13047 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1302384 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36663 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-268301 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-13047 usd
us-gaap Profit Loss
ProfitLoss
-1302384 usd
us-gaap Profit Loss
ProfitLoss
-36663 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109459182 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10335924 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109459182 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10335924 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-174625 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-148613 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1141564 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-13047 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18590963 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-26012 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23616 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49628 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13047 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-62675 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1302385 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36663 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
453772 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-32913 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-52701 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3750 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
340713 usd
arat Increase Decrease In Derivative Interest
IncreaseDecreaseInDerivativeInterest
5969 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1474114 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
18550285 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18550285 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
518500 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
20081273 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20599773 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
575374 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32453 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
542921 usd
CY2023Q2 arat Working Capital Deficit
WorkingCapitalDeficit
18590963 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2203297 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zbEJrKe8MbE7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_869_zGIb0kk2qtAd">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p>
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109459182 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109459182 shares
CY2021Q1 arat Common Stock Issued For Loan And Compensation Expenses
CommonStockIssuedForLoanAndCompensationExpenses
100000 usd
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
16166 usd
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
83834 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
50175 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
11862 usd

Files In Submission

Name View Source Status
0001753926-23-000809-index-headers.html Edgar Link pending
0001753926-23-000809-index.html Edgar Link pending
0001753926-23-000809.txt Edgar Link pending
0001753926-23-000809-xbrl.zip Edgar Link pending
arat-20230430.xsd Edgar Link pending
arat-20230430_cal.xml Edgar Link unprocessable
arat-20230430_def.xml Edgar Link unprocessable
arat-20230430_lab.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g083599_10q.htm Edgar Link pending
g083599_ex31-1.htm Edgar Link pending
g083599_ex31-2.htm Edgar Link pending
g083599_ex32-1.htm Edgar Link pending
g083599_ex32-2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
arat-20230430_pre.xml Edgar Link unprocessable
g083599_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable